| 64.73 Data as of Jun 06 |  +1.08 / +1.70%Today’s Change | 50.40 Today|||52-Week Range 68.83 | +12.11% Year-to-Date |
| STJ Begins U.S. Trial for EnligHTN - Analyst Blog Jun 05 / Zacks.com | A Major User of Masimo Expertise - Analyst Blog May 29 / Zacks.com |
| COV Begins Nellcor Labeling Process - Analyst Blog May 31 / Zacks.com | Covidien Downgraded to Underperform - Analyst Blog May 28 / Zacks.com |
| COV Progresses Further with Spin-Off - Analyst Blog May 30 / Zacks.com | St. Jude Begins EnligHTNment Study - Analyst Blog May 24 / Zacks.com |
| Previous close | 63.65 |
| Today’s open | 63.73 |
| Day’s range | 63.45 - 64.73 |
| Volume | 2,471,766 |
| Average volume (3 months) | 2,610,238 |
| Market cap | $29.9B |
| Dividend yield | 1.61% |
| Earnings growth (last year) | +3.40% |
| Earnings growth (this year) | +0.66% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | +2.40% |
| P/E ratio | -- |
| Price/Sales | 2.41 |
| Price/Book | 2.84 |
| Today’s change | Today’s % change | |
|---|---|---|
| SYKStryker Corp | +0.63 | +0.96% |
| BDXBecton Dickinson and... | +0.83 | +0.86% |
| ZMHZimmer Holdings Inc | +1.13 | +1.46% |
| BSXBoston Scientific Co... | +0.18 | +2.00% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $1.08 |
| Annual revenue (last year) | $11.9B |
| Annual profit (last year) | $1.9B |
| Net profit margin | 16.05% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer José E. Almeida |
Senior Vice President-Quality & Operations Michael Sgrignari |
Corporate headquarters Dublin, Dublin |
.
